Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Cardiology

Clinical Pharmacology

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial

ESC Heart Failure | Nov 26, 2021 Clinical Pharmacology

Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention

ESC Heart Failure | Nov 26, 2021 Clinical Pharmacology

Outcomes associated with catheter ablation of VT in patients with cardiac sarcoidosis

JAMA | Nov 22, 2021 Clinical Pharmacology

Sacubitril/valsartan vs standard therapy on plasma NT-proBNP and exercise capacity in HFpEF

JAMA | Nov 21, 2021 Clinical Pharmacology

Milvexian for the prevention of venous thromboembolism

New England Journal of Medicine | Nov 20, 2021 Clinical Pharmacology

Meta‐analysis of intravascular volume expansion strategies to prevent contrast‐associated acute kidney injury following invasive angiography

Catheterization and Cardiovascular Interventions | Nov 20, 2021 Clinical Pharmacology

Management of severe and moderate hypercholesterolemia in young women and men

JAMA | Nov 19, 2021 Clinical Pharmacology

Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved Trial

Circulation | Nov 19, 2021 Clinical Pharmacology

Secondary antibiotic prophylaxis for latent rheumatic heart disease

New England Journal of Medicine | Nov 18, 2021 Clinical Pharmacology

Efpeglenatide and clinical outcomes with and without concomitant sodium- glucose co-transporter-2 inhibition use in type 2 diabetes: Exploratory analysis of the AMPLITUDE-O Trial

Circulation | Nov 18, 2021 Clinical Pharmacology

« Prev 1 … 4 5 6 7 8 … 163 Next »

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial

Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention

Outcomes associated with catheter ablation of VT in patients with cardiac sarcoidosis

Sacubitril/valsartan vs standard therapy on plasma NT-proBNP and exercise capacity in HFpEF

Milvexian for the prevention of venous thromboembolism

Meta‐analysis of intravascular volume expansion strategies to prevent contrast‐associated acute kidney injury following invasive angiography

Management of severe and moderate hypercholesterolemia in young women and men

Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved Trial

Secondary antibiotic prophylaxis for latent rheumatic heart disease

Efpeglenatide and clinical outcomes with and without concomitant sodium- glucose co-transporter-2 inhibition use in type 2 diabetes: Exploratory analysis of the AMPLITUDE-O Trial

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

Cancer Drug Resistance in Innovative Strategies: A Scientific Review

Role of Genetic Counselling in Cancer Care

Eligibility of patients with heart failure with preserved ejection fraction for sacubitril/valsartan according to the PARAGON-HF trial

Long-term impact of β-blocker in elderly patients without myocardial infarction after percutaneous coronary intervention

Outcomes associated with catheter ablation of VT in patients with cardiac sarcoidosis

Sacubitril/valsartan vs standard therapy on plasma NT-proBNP and exercise capacity in HFpEF

Milvexian for the prevention of venous thromboembolism

Meta‐analysis of intravascular volume expansion strategies to prevent contrast‐associated acute kidney injury following invasive angiography

Management of severe and moderate hypercholesterolemia in young women and men

Empagliflozin, health status, and quality of life in patients with heart failure and preserved ejection fraction: The EMPEROR-Preserved Trial

Secondary antibiotic prophylaxis for latent rheumatic heart disease

Efpeglenatide and clinical outcomes with and without concomitant sodium- glucose co-transporter-2 inhibition use in type 2 diabetes: Exploratory analysis of the AMPLITUDE-O Trial

'Weekend Warrior' Trend: Health Perks for Busy Physicians

Minimally Invasive Dentistry

Leptin Hormone: Its Role in Food Intake & Energy Expenditure

Cancer Drug Resistance in Innovative Strategies: A Scientific Review

Role of Genetic Counselling in Cancer Care

Select Specialty

Select Topic